Top compounds associated with response to PRKCQ


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.057 0.2
mRNA tivozanib GDSC1000 pan-cancer AAC 0.13 0.0005
mRNA tivozanib CTRPv2 pan-cancer AAC 0.13 0.0009
mRNA tosedostat CTRPv2 pan-cancer AAC 0.02 0.6
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.2
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.008
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.056 0.08
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.07 0.1
mRNA triptolide CTRPv2 pan-cancer AAC 0.031 0.4
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.072 0.03
Download CSV